1. 98PIdentification of a highly suppressive Treg subset associated to immunotherapy response. (23rd October 2018) Authors: Giunta, E F; Romano, S; D'Arrigo, P; Rea, A; Tufano, M; Matarese, G; Procaccini, C; Novizio, N; Vigorito, V; Faicchia, D; Argenziano, G; De Falco, V; Ciardiello, F; Romano, M F; Troiani, T Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma. Issue 12 (2nd December 2017) Authors: Grande, E; Glen, H; Aller, J; Argenziano, G; Lamas, MJ; Ruszniewski, P; Zamorano, JL; Edmonds, K; Sarker, S; Staehler, M; Larkin, J Journal: Expert opinion on drug safety Issue: Volume 16:Issue 12(2017:Dec.) Page Start: 1413 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗